{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:05:37Z","timestamp":1785769537408,"version":"3.56.0"},"reference-count":193,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.bbalip.2020.158658","type":"journal-article","created":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T02:04:09Z","timestamp":1581300249000},"page":"158658","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Role of lipids in pathophysiology, diagnosis and therapy of hepatocellular carcinoma"],"prefix":"10.1016","volume":"1865","author":[{"given":"Christa","family":"Buechler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalampos","family":"Aslanidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbalip.2020.158658_bb0005","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbalip.2020.158658_bb0010","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jhep.2018.05.011","article-title":"Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies","volume":"69","author":"Pimpin","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbalip.2020.158658_bb0015","first-page":"2801","article-title":"Adiponectin, a key adipokine in obesity related liver diseases","volume":"17","author":"Buechler","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbalip.2020.158658_bb0020","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-med-090514-013832","article-title":"Liver cancer: connections with obesity, fatty liver, and cirrhosis","volume":"67","author":"Marengo","year":"2015","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.bbalip.2020.158658_bb0025","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.jhep.2011.10.027","article-title":"Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace","volume":"56","author":"Baffy","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbalip.2020.158658_bb0030","doi-asserted-by":"crossref","DOI":"10.1111\/liv.14223","article-title":"Biology and significance of alpha-fetoprotein in hepatocellular carcinoma","author":"Galle","year":"2019","journal-title":"Liver Int."},{"key":"10.1016\/j.bbalip.2020.158658_bb0035","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3727\/096504017X15051752095738","article-title":"Efficacy and safety of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion in hepatocellular carcinoma: a systematic review and meta-analysis","volume":"26","author":"Liu","year":"2018","journal-title":"Oncol. Res."},{"key":"10.1016\/j.bbalip.2020.158658_bb0040","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2217\/hep-2016-0012","article-title":"Dysregulated fatty acid metabolism in hepatocellular carcinoma","volume":"3","author":"Wang","year":"2016","journal-title":"Hepat Oncol"},{"key":"10.1016\/j.bbalip.2020.158658_bb0045","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/MOL.0000000000000569","article-title":"Lipoprotein metabolism in liver diseases","volume":"30","author":"Perez-Matos","year":"2019","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbalip.2020.158658_bb0050","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s10620-017-4862-x","article-title":"Abnormalities of lipoprotein levels in liver cirrhosis: clinical relevance","volume":"63","author":"Privitera","year":"2018","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.bbalip.2020.158658_bb0055","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1080\/078538902320772098","article-title":"ABCA1: regulation, trafficking and association with heteromeric proteins","volume":"34","author":"Schmitz","year":"2002","journal-title":"Ann. Med."},{"key":"10.1016\/j.bbalip.2020.158658_bb0060","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1159\/000371678","article-title":"Gut microbiota, cirrhosis, and alcohol regulate bile acid metabolism in the gut","volume":"33","author":"Ridlon","year":"2015","journal-title":"Dig. Dis."},{"key":"10.1016\/j.bbalip.2020.158658_bb0065","doi-asserted-by":"crossref","first-page":"70","DOI":"10.14797\/mdcj-15-1-70","article-title":"The TICE pathway: mechanisms and lipid-lowering therapies","volume":"15","author":"Grefhorst","year":"2019","journal-title":"Methodist Debakey Cardiovasc. J."},{"key":"10.1016\/j.bbalip.2020.158658_bb0070","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.atherosclerosis.2010.01.011","article-title":"ABC transporters, atherosclerosis and inflammation","volume":"211","author":"Fitzgerald","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2020.158658_bb0075","doi-asserted-by":"crossref","DOI":"10.1177\/1073274817729235","article-title":"Staging and prognostic models for hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"24","author":"Burkhart","year":"2017","journal-title":"Cancer Control"},{"key":"10.1016\/j.bbalip.2020.158658_bb0080","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.3390\/v5051292","article-title":"Hepatitis C virus, cholesterol and lipoproteins\u2014impact for the viral life cycle and pathogenesis of liver disease","volume":"5","author":"Felmlee","year":"2013","journal-title":"Viruses"},{"key":"10.1016\/j.bbalip.2020.158658_bb0085","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10238-013-0262-5","article-title":"The effect of the severity of liver cirrhosis on the level of lipids and lipoproteins","volume":"14","author":"Chrostek","year":"2014","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.bbalip.2020.158658_bb0090","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1159\/000339206","article-title":"Lipid serum profile in patients with viral liver cirrhosis","volume":"21","author":"Vere","year":"2012","journal-title":"Med. Princ. Pract."},{"key":"10.1016\/j.bbalip.2020.158658_bb0095","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1590\/S0004-28032015000300011","article-title":"Lipid profile of cirrhotic patients and its association with prognostic scores: a cross-sectional study","volume":"52","author":"Bassani","year":"2015","journal-title":"Arq. Gastroenterol."},{"key":"10.1016\/j.bbalip.2020.158658_bb0100","doi-asserted-by":"crossref","first-page":"318627","DOI":"10.1155\/2012\/318627","article-title":"Improving survival in decompensated cirrhosis","volume":"2012","author":"Mukerji","year":"2012","journal-title":"Int J Hepatol"},{"key":"10.1016\/j.bbalip.2020.158658_bb0105","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.prostaglandins.2017.06.004","article-title":"Associations of systemic sphingolipids with measures of hepatic function in liver cirrhosis are related to cholesterol","volume":"131","author":"Krautbauer","year":"2017","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.bbalip.2020.158658_bb0110","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","article-title":"Comprehensive and integrative genomic characterization of hepatocellular carcinoma","volume":"169","author":"w.b.e. Cancer Genome Atlas Research Network. Electronic address, N. Cancer Genome Atlas Research","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.bbalip.2020.158658_bb0115","doi-asserted-by":"crossref","first-page":"28106","DOI":"10.1074\/jbc.M403176200","article-title":"The hepatitis B virus X protein inhibits secretion of apolipoprotein B by enhancing the expression of N-acetylglucosaminyltransferase III","volume":"279","author":"Kang","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2020.158658_bb0120","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4149\/neo_2014_001","article-title":"Screening differential expression of serum proteins in AFP-negative HBV-related hepatocellular carcinoma using iTRAQ -MALDI-MS\/MS","volume":"61","author":"He","year":"2014","journal-title":"Neoplasma"},{"key":"10.1016\/j.bbalip.2020.158658_bb0125","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.2147\/OTT.S192631","article-title":"Elevated apolipoprotein B predicts poor postsurgery prognosis in patients with hepatocellular carcinoma","volume":"12","author":"Yan","year":"2019","journal-title":"OncoTargets and therapy"},{"key":"10.1016\/j.bbalip.2020.158658_bb0130","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2013.05.017","article-title":"Cellular fatty acid metabolism and cancer","volume":"18","author":"Currie","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbalip.2020.158658_bb0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.livres.2017.05.001","article-title":"Bile acid metabolism and signaling in liver disease and therapy","volume":"1","author":"Chiang","year":"2017","journal-title":"Liver Res"},{"key":"10.1016\/j.bbalip.2020.158658_bb0140","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.plefa.2009.08.003","article-title":"Altered lipid profile, oxidative status and hepatitis B virus interactions in human hepatocellular carcinoma","volume":"81","author":"Abel","year":"2009","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.bbalip.2020.158658_bb0145","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.bbalip.2016.08.014","article-title":"Ceramide and polyunsaturated phospholipids are strongly reduced in human hepatocellular carcinoma","volume":"1861","author":"Krautbauer","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2020.158658_bb0150","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/bjc.2015.38","article-title":"Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review","volume":"112","author":"Kimhofer","year":"2015","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbalip.2020.158658_bb0155","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s12551-017-0297-z","article-title":"The many faces (and phases) of ceramide and sphingomyelin I - single lipids","volume":"9","author":"Fanani","year":"2017","journal-title":"Biophys. Rev."},{"key":"10.1016\/j.bbalip.2020.158658_bb0160","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.bbalip.2013.08.019","article-title":"Ceramide synthases as potential targets for therapeutic intervention in human diseases","volume":"1841","author":"Park","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2020.158658_bb0165","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/S0022-2275(20)34422-9","article-title":"Lateral chain packing in lipids and membranes","volume":"25","author":"Small","year":"1984","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2020.158658_bb0170","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.3390\/ijms15057124","article-title":"SREBP-1 has a prognostic role and contributes to invasion and metastasis in human hepatocellular carcinoma","volume":"15","author":"Li","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbalip.2020.158658_bb0175","article-title":"Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans","author":"Che","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.bbalip.2020.158658_bb0180","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jhep.2015.10.004","article-title":"Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans","volume":"64","author":"Li","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbalip.2020.158658_bb0185","doi-asserted-by":"crossref","first-page":"20484","DOI":"10.1038\/srep20484","article-title":"Co-activation of AKT and c-Met triggers rapid hepatocellular carcinoma development via the mTORC1\/FASN pathway in mice","volume":"6","author":"Hu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbalip.2020.158658_bb0190","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aar6849","article-title":"Genes for de novo biosynthesis of omega-3 polyunsaturated fatty acids are widespread in animals","volume":"4","author":"Kabeya","year":"2018","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbalip.2020.158658_bb0195","doi-asserted-by":"crossref","first-page":"8117","DOI":"10.1158\/0008-5472.CAN-09-3871","article-title":"De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation","volume":"70","author":"Rysman","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbalip.2020.158658_bb0200","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1158\/0008-5472.CAN-13-0308","article-title":"Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics","volume":"73","author":"Huang","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbalip.2020.158658_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122550","article-title":"Aberrant lipid metabolism in hepatocellular carcinoma revealed by liver lipidomics","volume":"18","author":"Li","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbalip.2020.158658_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/nu10040432","article-title":"Obesity, inflammation, toll-like receptor 4 and fatty acids","volume":"10","author":"Rogero","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.bbalip.2020.158658_bb0215","doi-asserted-by":"crossref","DOI":"10.1007\/s12026-019-09075-x","article-title":"Prognostic impact of toll-like receptors 2 and 4 expression on monocytes in Egyptian patients with hepatocellular carcinoma","author":"Zahran","year":"2019","journal-title":"Immunol. Res."},{"key":"10.1016\/j.bbalip.2020.158658_bb0220","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/14728222.2019.1615883","article-title":"Aberrant lipid metabolism as a therapeutic target in liver cancer","volume":"23","author":"Pope","year":"2019","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bbalip.2020.158658_bb0225","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/hep.29033","article-title":"Functional lipidomics: palmitic acid impairs hepatocellular carcinoma development by modulating membrane fluidity and glucose metabolism","volume":"66","author":"Lin","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.bbalip.2020.158658_bb0230","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jhep.2017.06.015","article-title":"Stearoyl-CoA desaturase regulates sorafenib resistance via modulation of ER stress-induced differentiation","volume":"67","author":"Ma","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbalip.2020.158658_bb0235","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1111\/cas.13659","article-title":"Role of caveolin-1 in hepatocellular carcinoma arising from non-alcoholic fatty liver disease","volume":"109","author":"Takeda","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbalip.2020.158658_bb0240","doi-asserted-by":"crossref","DOI":"10.1038\/s41366-019-0431-z","article-title":"Specific diacylglycerols generated by hepatic lipogenesis stimulate the oncogenic androgen receptor activity in male hepatocytes","author":"Cheng","year":"2019","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.bbalip.2020.158658_bb0245","doi-asserted-by":"crossref","first-page":"7498","DOI":"10.1038\/s41598-017-07685-9","article-title":"Oleate but not stearate induces the regulatory phenotype of myeloid suppressor cells","volume":"7","author":"Wu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbalip.2020.158658_bb0250","doi-asserted-by":"crossref","first-page":"14752","DOI":"10.1038\/srep14752","article-title":"Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma","volume":"5","author":"Nath","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbalip.2020.158658_bb0255","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1038\/s41388-018-0597-1","article-title":"Endothelial fatty liver binding protein 4: a new targetable mediator in hepatocellular carcinoma related to metabolic syndrome","volume":"38","author":"Laouirem","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.bbalip.2020.158658_bb0260","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/liv.13183","article-title":"Both de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells","volume":"37","author":"Cao","year":"2017","journal-title":"Liver Int."},{"key":"10.1016\/j.bbalip.2020.158658_bb0265","doi-asserted-by":"crossref","DOI":"10.3390\/cells8050512","article-title":"Characterization of lipid and lipid droplet metabolism in human HCC","volume":"8","author":"Berndt","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bbalip.2020.158658_bb0270","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.3748\/wjg.v25.i30.4199","article-title":"Multiple \u201comics\u201d data-based biomarker screening for hepatocellular carcinoma diagnosis","volume":"25","author":"Liu","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbalip.2020.158658_bb0275","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1158\/0008-5472.CAN-12-3797","article-title":"Proteomic and lipidomic signatures of lipid metabolism in NASH-associated hepatocellular carcinoma","volume":"73","author":"Muir","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbalip.2020.158658_bb0280","doi-asserted-by":"crossref","first-page":"6590","DOI":"10.1158\/0008-5472.CAN-11-0885","article-title":"Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling","volume":"71","author":"Patterson","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbalip.2020.158658_bb0285","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1158\/1940-6207.CAPR-17-0249","article-title":"Metabolomics profiles of hepatocellular carcinoma in a Korean prospective cohort: the Korean cancer prevention study-II","volume":"11","author":"Jee","year":"2018","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/j.bbalip.2020.158658_bb0290","article-title":"Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma","volume":"10","author":"Chen","year":"2011","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.bbalip.2020.158658_bb0295","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/ijc.28706","article-title":"NMR and LC\/MS-based global metabolomics to identify serum biomarkers differentiating hepatocellular carcinoma from liver cirrhosis","volume":"135","author":"Liu","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbalip.2020.158658_bb0300","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00216-012-5782-4","article-title":"Serum metabolomics reveals the deregulation of fatty acids metabolism in hepatocellular carcinoma and chronic liver diseases","volume":"403","author":"Zhou","year":"2012","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.bbalip.2020.158658_bb0305","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/CIRCRESAHA.115.306246","article-title":"Microdomains, inflammation, and atherosclerosis","volume":"118","author":"Sorci-Thomas","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbalip.2020.158658_bb0310","doi-asserted-by":"crossref","first-page":"63856","DOI":"10.18632\/oncotarget.11697","article-title":"Lipid rafts promote liver cancer cell proliferation and migration by up-regulation of TLR7 expression","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbalip.2020.158658_bb0315","article-title":"Targeting the raft-associated Akt signaling in hepatocellular carcinoma","author":"Liu","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.bbalip.2020.158658_bb0320","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1158\/0008-5472.CAN-18-2603","article-title":"CD317 activates EGFR by regulating its association with lipid rafts","volume":"79","author":"Zhang","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbalip.2020.158658_bb0325","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1242\/dmm.011338","article-title":"Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development","volume":"6","author":"Baenke","year":"2013","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.bbalip.2020.158658_bb0330","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.bbamem.2017.04.006","article-title":"The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease","volume":"1859","author":"van der Veen","year":"2017","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.bbalip.2020.158658_bb0335","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2174\/187152012800228689","article-title":"Hepatocarcinogenesis and ceramide\/cholesterol metabolism","volume":"12","author":"Morales","year":"2012","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.bbalip.2020.158658_bb0340","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1194\/jlr.R039297","article-title":"Thematic review series: high density lipoprotein structure, function, and metabolism cardioprotective functions of HDLs","volume":"55","author":"Rye","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2020.158658_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2017.06.046","article-title":"High density lipoproteins exert pro-inflammatory effects on macrophages via passive cholesterol depletion and Pkc-Nf-Kb\/Stat1-Irf1 signaling","volume":"263","author":"Van Der Vorst","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2020.158658_bb0350","first-page":"219","article-title":"Studies on the biosynthesis of polyisoprenols, cholesterol and ubiquinone in highly differentiated human hepatomas","volume":"71","author":"Eggens","year":"1990","journal-title":"J. Exp. Pathol. (Oxford)"},{"key":"10.1016\/j.bbalip.2020.158658_bb0355","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/jmcb\/mjt039","article-title":"A specific cholesterol metabolic pathway is established in a subset of HCCs for tumor growth","volume":"5","author":"Lu","year":"2013","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.bbalip.2020.158658_bb0360","doi-asserted-by":"crossref","first-page":"47","DOI":"10.21037\/tgh.2019.06.03","article-title":"Proteomic profiling in liver cancer: another new page","volume":"4","author":"Chan","year":"2019","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10.1016\/j.bbalip.2020.158658_bb0365","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jhep.2014.03.018","article-title":"Acyl-CoA:cholesterol acyltransferase 1 mediates liver fibrosis by regulating free cholesterol accumulation in hepatic stellate cells","volume":"61","author":"Tomita","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbalip.2020.158658_bb0370","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127299","article-title":"GC-MS based plasma metabolomics for identification of candidate biomarkers for hepatocellular carcinoma in Egyptian cohort","volume":"10","author":"Nezami Ranjbar","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2020.158658_bb0375","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1477-2574.2010.00207.x","article-title":"Evidence of aberrant lipid metabolism in hepatitis C and hepatocellular carcinoma","volume":"12","author":"Wu","year":"2010","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.bbalip.2020.158658_bb0380","first-page":"3527","article-title":"Diagnostic value of systemic cholesteryl ester\/free cholesterol ratio in hepatocellular carcinoma","volume":"37","author":"Krautbauer","year":"2017","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbalip.2020.158658_bb0385","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0026-0495(93)90166-L","article-title":"Lecithin-cholesterol acyltransferase and lipid transfer protein activities in liver disease","volume":"42","author":"Tahara","year":"1993","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.bbalip.2020.158658_bb0390","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1053\/j.gastro.2010.12.006","article-title":"Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma","volume":"140","author":"Calvisi","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbalip.2020.158658_bb0395","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2174\/138920112799095365","article-title":"ATP binding cassette transporter A1 (ABCA1) associated proteins: potential drug targets in the metabolic syndrome and atherosclerotic disease?","volume":"13","author":"Buechler","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.bbalip.2020.158658_bb0400","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/hep.24682","article-title":"Adenosine triphosphate-binding cassette transporter genes up-regulation in untreated hepatocellular carcinoma is mediated by cellular microRNAs","volume":"55","author":"Borel","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.bbalip.2020.158658_bb0405","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1349-7006.2004.tb03244.x","article-title":"Comparative analysis of ATP-binding cassette (ABC) transporter gene expression levels in peripheral blood leukocytes and in liver with hepatocellular carcinoma","volume":"95","author":"Moustafa","year":"2004","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbalip.2020.158658_bb0410","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/s41598-018-38110-4","article-title":"Statin use is associated with decreased hepatocellular carcinoma recurrence in liver transplant patients","volume":"9","author":"Cho","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbalip.2020.158658_bb0415","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jhep.2017.10.018","article-title":"Statin use and the risk of hepatocellular carcinoma in patients at high risk: a nationwide nested case-control study","volume":"68","author":"Kim","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbalip.2020.158658_bb0420","doi-asserted-by":"crossref","first-page":"6201","DOI":"10.3748\/wjg.v22.i27.6201","article-title":"Pleiotropic effects of statins in the diseases of the liver","volume":"22","author":"Janicko","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbalip.2020.158658_bb0425","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19123871","article-title":"Perturbing the dynamics and organization of cell membrane components: a new paradigm for cancer-targeted therapies","volume":"19","author":"Bernardes","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbalip.2020.158658_bb0430","doi-asserted-by":"crossref","first-page":"30483","DOI":"10.1038\/srep30483","article-title":"Inactivation of hypoxia-induced YAP by statins overcomes hypoxic resistance tosorafenib in hepatocellular carcinoma cells","volume":"6","author":"Zhou","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbalip.2020.158658_bb0435","doi-asserted-by":"crossref","first-page":"101214","DOI":"10.1016\/j.redox.2019.101214","article-title":"Cholesterol enrichment in liver mitochondria impairs oxidative phosphorylation and disrupts the assembly of respiratory supercomplexes","volume":"24","author":"Solsona-Vilarrasa","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.bbalip.2020.158658_bb0440","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/164_2016_110","article-title":"Mitochondrial cholesterol and the paradox in cell death","volume":"240","author":"Garcia-Ruiz","year":"2017","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.bbalip.2020.158658_bb0445","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ccr.2012.01.001","article-title":"Conflicting roles of molecules in hepatocarcinogenesis: paradigm or paradox","volume":"21","author":"Feng","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbalip.2020.158658_bb0450","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.canlet.2018.04.038","article-title":"Cholesterol inhibits hepatocellular carcinoma invasion and metastasis by promoting CD44 localization in lipid rafts","volume":"429","author":"Yang","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbalip.2020.158658_bb0455","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","article-title":"Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis","volume":"15","author":"Jia","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbalip.2020.158658_bb0460","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.canlet.2019.04.009","article-title":"Glycochenodeoxycholate promotes hepatocellular carcinoma invasion and migration by AMPK\/mTOR dependent autophagy activation","volume":"454","author":"Gao","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbalip.2020.158658_bb0465","doi-asserted-by":"crossref","first-page":"10899","DOI":"10.1002\/jcp.27905","article-title":"Bile salt (glycochenodeoxycholate acid) induces cell survival and chemoresistance in hepatocellular carcinoma","volume":"234","author":"Wang","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbalip.2020.158658_bb0470","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s40139-012-0003-6","article-title":"Bile acid receptors and liver cancer","volume":"1","author":"Wang","year":"2013","journal-title":"Curr Pathobiol Rep"},{"key":"10.1016\/j.bbalip.2020.158658_bb0475","doi-asserted-by":"crossref","first-page":"G295","DOI":"10.1152\/ajpgi.00134.2015","article-title":"Mice with hepatocyte-specific FXR deficiency are resistant to spontaneous but susceptible to cholic acid-induced hepatocarcinogenesis","volume":"310","author":"Kong","year":"2016","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbalip.2020.158658_bb0480","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2174\/18715281113126660060","article-title":"Diagnostic and prognostic potential of the macrophage specific receptor CD163 in inflammatory diseases","volume":"12","author":"Buechler","year":"2013","journal-title":"Inflamm. Allergy Drug Targets"},{"key":"10.1016\/j.bbalip.2020.158658_bb0485","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan2507","article-title":"A pathology atlas of the human cancer transcriptome","volume":"357","author":"Uhlen","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.bbalip.2020.158658_bb0490","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/BF02774522","article-title":"Serum, fecal and urinary bile acids in patients with mild and advanced liver cirrhosis","volume":"16","author":"Amuro","year":"1981","journal-title":"Gastroenterol. Jpn."},{"key":"10.1016\/j.bbalip.2020.158658_bb0495","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.aca.2011.02.038","article-title":"Fecal metabolome profiling of liver cirrhosis and hepatocellular carcinoma patients by ultra performance liquid chromatography-mass spectrometry","volume":"691","author":"Cao","year":"2011","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.bbalip.2020.158658_bb0500","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.3748\/wjg.v19.i22.3423","article-title":"Human liver tissue metabolic profiling research on hepatitis B virus-related hepatocellular carcinoma","volume":"19","author":"Liu","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbalip.2020.158658_bb0505","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/gut.12.2.145","article-title":"Serum bile acids in liver disease","volume":"12","author":"Neale","year":"1971","journal-title":"Gut"},{"key":"10.1016\/j.bbalip.2020.158658_bb0510","first-page":"223","article-title":"Blood cholates in normal subjects and in liver disease","volume":"6","author":"Sherlock","year":"1948","journal-title":"Clin. Sci."},{"key":"10.1016\/j.bbalip.2020.158658_bb0515","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jhep.2013.01.003","article-title":"Modulation of the fecal bile acid profile by gut microbiota in cirrhosis","volume":"58","author":"Kakiyama","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbalip.2020.158658_bb0520","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1021\/acs.jproteome.5b00217","article-title":"Serum bile acids are associated with pathological progression of hepatitis B-induced cirrhosis","volume":"15","author":"Wang","year":"2016","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbalip.2020.158658_bb0525","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/gut.11.5.420","article-title":"Abnormal metabolism of secondary bile acids in patients with cirrhosis","volume":"11","author":"Vlahcevic","year":"1970","journal-title":"Gut"},{"key":"10.1016\/j.bbalip.2020.158658_bb0530","doi-asserted-by":"crossref","first-page":"5914","DOI":"10.1021\/pr300673x","article-title":"LC-MS based serum metabolomics for identification of hepatocellular carcinoma biomarkers in Egyptian cohort","volume":"11","author":"Xiao","year":"2012","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbalip.2020.158658_bb0535","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.aca.2012.07.013","article-title":"Utilization of metabolomics to identify serum biomarkers for hepatocellular carcinoma in patients with liver cirrhosis","volume":"743","author":"Ressom","year":"2012","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.bbalip.2020.158658_bb0540","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1021\/pr2009252","article-title":"Metabonomic profiles discriminate hepatocellular carcinoma from liver cirrhosis by ultraperformance liquid chromatography-mass spectrometry","volume":"11","author":"Wang","year":"2012","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbalip.2020.158658_bb0545","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M111.010694","article-title":"Metabolomics study of stepwise hepatocarcinogenesis from the model rats to patients: potential biomarkers effective for small hepatocellular carcinoma diagnosis","volume":"11","author":"Tan","year":"2012","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.bbalip.2020.158658_bb0550","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fcell.2019.00152","article-title":"Sphingomyelin breakdown in T cells: role of membrane compartmentalization in T cell signaling and interference by a pathogen","volume":"7","author":"Avota","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbalip.2020.158658_bb0555","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1515\/hsz-2014-0310","article-title":"The effect of altered sphingolipid acyl chain length on various disease models","volume":"396","author":"Park","year":"2015","journal-title":"Biol. Chem."},{"key":"10.1016\/j.bbalip.2020.158658_bb0560","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-1-4419-6741-1_13","article-title":"Cancer treatment strategies targeting sphingolipid metabolism","volume":"688","author":"Oskouian","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbalip.2020.158658_bb0565","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1111\/liv.12903","article-title":"Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma","volume":"35","author":"Chettouh","year":"2015","journal-title":"Liver Int."},{"key":"10.1016\/j.bbalip.2020.158658_bb0570","doi-asserted-by":"crossref","DOI":"10.1194\/jlr.R094060","article-title":"Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication","author":"Funcke","year":"2019","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2020.158658_bb0575","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.bbalip.2016.08.016","article-title":"Regulation of glucose homeostasis and insulin action by ceramide acyl-chain length: a beneficial role for very long-chain sphingolipid species","volume":"1861","author":"Montgomery","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2020.158658_bb0580","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.18632\/oncotarget.23494","article-title":"Comparison of hepatic and serum lipid signatures in hepatocellular carcinoma patients leads to the discovery of diagnostic and prognostic biomarkers","volume":"9","author":"Lu","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbalip.2020.158658_bb0585","first-page":"1530","article-title":"Endocannabinoid system and the expression of endogenous ceramides in human hepatocellular carcinoma","volume":"18","author":"Yang","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbalip.2020.158658_bb0590","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1194\/jlr.M063412","article-title":"Hepatocytes release ceramide-enriched pro-inflammatory extracellular vesicles in an IRE1alpha-dependent manner","volume":"57","author":"Kakazu","year":"2016","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2020.158658_bb0595","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1002\/hep.27867","article-title":"Myeloid cells in hepatocellular carcinoma","volume":"62","author":"Wan","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.bbalip.2020.158658_bb0600","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1053\/j.gastro.2017.10.050","article-title":"Nanoliposome C6-ceramide increases the anti-tumor immune response and slows growth of liver tumors in mice","volume":"154","author":"Li","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbalip.2020.158658_bb0605","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/iub.319","article-title":"Mammalian ceramide synthases","volume":"62","author":"Levy","year":"2010","journal-title":"IUBMB Life"},{"key":"10.1016\/j.bbalip.2020.158658_bb0610","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.3892\/ol.2017.6365","article-title":"Ceramide synthase-4 orchestrates the cell proliferation and tumor growth of liver cancer in vitro and in vivo through the nuclear factor-kappaB signaling pathway","volume":"14","author":"Chen","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbalip.2020.158658_bb0615","doi-asserted-by":"crossref","first-page":"33549","DOI":"10.1074\/jbc.M109.031971","article-title":"Adult ceramide synthase 2 (CERS2)-deficient mice exhibit myelin sheath defects, cerebellar degeneration, and hepatocarcinomas","volume":"284","author":"Imgrund","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2020.158658_bb0620","doi-asserted-by":"crossref","first-page":"5763","DOI":"10.1007\/s13277-015-3245-1","article-title":"Ceramide production mediates cinobufotalin-induced growth inhibition and apoptosis in cultured hepatocellular carcinoma cells","volume":"36","author":"Cheng","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.bbalip.2020.158658_bb0625","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1136\/gut.2010.216671","article-title":"Nanoliposomal ceramide prevents in vivo growth of hepatocellular carcinoma","volume":"60","author":"Tagaram","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.bbalip.2020.158658_bb0630","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1158\/1078-0432.CCR-07-4881","article-title":"Combining nanoliposomal ceramide with sorafenib synergistically inhibits melanoma and breast cancer cell survival to decrease tumor development","volume":"14","author":"Tran","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbalip.2020.158658_bb0635","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1208\/s12249-018-1005-4","article-title":"Ceramide-fabricated co-loaded liposomes for the synergistic treatment of hepatocellular carcinoma","volume":"19","author":"Yin","year":"2018","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.bbalip.2020.158658_bb0640","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11523-019-00624-w","article-title":"The changing landscape of systemic treatment of advanced hepatocellular carcinoma: new targeted agents and immunotherapies","volume":"14","author":"Marquardt","year":"2019","journal-title":"Target. Oncol."},{"key":"10.1016\/j.bbalip.2020.158658_bb0645","doi-asserted-by":"crossref","first-page":"8253","DOI":"10.18632\/oncotarget.6982","article-title":"Targeting glucosylceramide synthase upregulation reverts sorafenib resistance in experimental hepatocellular carcinoma","volume":"16","author":"Stefanovic","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbalip.2020.158658_bb0650","doi-asserted-by":"crossref","first-page":"109201","DOI":"10.18632\/oncotarget.22648","article-title":"Inhibition of hepatocellular carcinoma growth by blockade of glycosphingolipid synthesis","volume":"8","author":"Jennemann","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbalip.2020.158658_bb0655","doi-asserted-by":"crossref","first-page":"178910","DOI":"10.1155\/2013\/178910","article-title":"Sphingolipid metabolic pathway: an overview of major roles played in human diseases","volume":"2013","author":"Pralhada Rao","year":"2013","journal-title":"Journal of lipids"},{"key":"10.1016\/j.bbalip.2020.158658_bb0660","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s12276-018-0150-x","article-title":"The implications of signaling lipids in cancer metastasis","volume":"50","author":"Luo","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbalip.2020.158658_bb0665","doi-asserted-by":"crossref","DOI":"10.1007\/164_2019_217","article-title":"Role of sphingosine kinase 1 and sphingosine-1-phosphate axis in hepatocellular carcinoma","author":"Maceyka","year":"2019","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.bbalip.2020.158658_bb0670","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1478-3231.2011.02666.x","article-title":"Sphingosine kinase 1 promotes tumour cell migration and invasion via the S1P\/EDG1 axis in hepatocellular carcinoma","volume":"32","author":"Bao","year":"2012","journal-title":"Liver Int."},{"key":"10.1016\/j.bbalip.2020.158658_bb0675","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149462","article-title":"Increased mRNA levels of sphingosine kinases and S1P Lyase and reduced levels of S1P were observed in hepatocellular carcinoma in association with poorer differentiation and earlier recurrence","volume":"11","author":"Uranbileg","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2020.158658_bb0680","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1007\/s10637-010-9452-0","article-title":"Combined anticancer effects of sphingosine kinase inhibitors and sorafenib","volume":"29","author":"Beljanski","year":"2011","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.bbalip.2020.158658_bb0685","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1194\/jlr.D800028-JLR200","article-title":"Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry","volume":"50","author":"Wiesner","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2020.158658_bb0690","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1194\/jlr.R059543","article-title":"Sources, metabolism, and regulation of circulating sphingosine-1-phosphate","volume":"56","author":"Ksiazek","year":"2015","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2020.158658_bb0695","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138130","article-title":"Serum sphingolipid variations associate with hepatic decompensation and survival in patients with cirrhosis","volume":"10","author":"Grammatikos","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2020.158658_bb0700","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.7741","article-title":"Serum sphingolipidomic analyses reveal an upregulation of C16- ceramide and sphingosine-1-phosphate in hepatocellular carcinoma","author":"Grammatikos","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbalip.2020.158658_bb0705","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174424","article-title":"Low sphingosine-1-phosphate plasma levels are predictive for increased mortality in patients with liver cirrhosis","volume":"12","author":"Becker","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2020.158658_bb0710","doi-asserted-by":"crossref","DOI":"10.1111\/liv.14178","article-title":"Serum sphingolipids predict de novo hepatocellular carcinoma in hepatitis C cirrhotic patients with sustained virologic response","author":"Mucke","year":"2019","journal-title":"Liver Int."},{"key":"10.1016\/j.bbalip.2020.158658_bb0715","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1002\/elps.201200629","article-title":"Serum lipid profiling of patients with chronic hepatitis B, cirrhosis, and hepatocellular carcinoma by ultra fast LC\/IT-TOF MS","volume":"34","author":"Chen","year":"2013","journal-title":"Electrophoresis"},{"key":"10.1016\/j.bbalip.2020.158658_bb0720","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1039\/b820224a","article-title":"A metabonomic study of hepatitis B-induced liver cirrhosis and hepatocellular carcinoma by using RP-LC and HILIC coupled with mass spectrometry","volume":"5","author":"Yin","year":"2009","journal-title":"Mol. BioSyst."},{"key":"10.1016\/j.bbalip.2020.158658_bb0725","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.18632\/oncotarget.26738","article-title":"Phospholipid profiles and hepatocellular carcinoma risk and prognosis in cirrhotic patients","volume":"10","author":"Cotte","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbalip.2020.158658_bb0730","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1194\/jlr.D005322","article-title":"A rapid and quantitative LC-MS\/MS method to profile sphingolipids","volume":"51","author":"Scherer","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2020.158658_bb0735","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20051149","article-title":"An updated review of lysophosphatidylcholine metabolism in human diseases","volume":"20","author":"Law","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbalip.2020.158658_bb0740","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.mce.2017.12.002","article-title":"Lysophosphatidylcholine and its phosphorothioate analogues potentiate insulin secretion via GPR40 (FFAR1), GPR55 and GPR119 receptors in a different manner","volume":"472","author":"Drzazga","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbalip.2020.158658_bb0745","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jhep.2013.02.030","article-title":"Lysophosphatidylcholine acyltransferase 1 altered phospholipid composition and regulated hepatoma progression","volume":"59","author":"Morita","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbalip.2020.158658_bb0750","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1476-4598-9-71","article-title":"Autotaxin expression and its connection with the TNF-alpha-NF-kappaB axis in human hepatocellular carcinoma","volume":"9","author":"Wu","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbalip.2020.158658_bb0755","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.cca.2011.03.014","article-title":"Autotaxin as a novel serum marker of liver fibrosis","volume":"412","author":"Nakagawa","year":"2011","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbalip.2020.158658_bb0760","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0140-6736(90)91777-8","article-title":"LCAT activity as a prognostic liver function test","volume":"336","author":"Horton","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.bbalip.2020.158658_bb0765","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4254\/wjh.v9.i1.1","article-title":"Disease monitoring of hepatocellular carcinoma through metabolomics","volume":"9","author":"Fitian","year":"2017","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.bbalip.2020.158658_bb0770","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/liv.12541","article-title":"Integrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC\/MS and UPLC\/MS-MS","volume":"34","author":"Fitian","year":"2014","journal-title":"Liver Int."},{"key":"10.1016\/j.bbalip.2020.158658_bb0775","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.prostaglandins.2016.06.001","article-title":"Systemic saturated lysophosphatidylcholine is associated with hepatic function in patients with liver cirrhosis","volume":"124","author":"Krautbauer","year":"2016","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.bbalip.2020.158658_bb0780","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1021\/pr300683a","article-title":"Serum metabolic profiling study of hepatocellular carcinoma infected with hepatitis B or hepatitis C virus by using liquid chromatography-mass spectrometry","volume":"11","author":"Zhou","year":"2012","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbalip.2020.158658_bb0785","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.3892\/ol.2017.5596","article-title":"Metabolic profiling of hepatitis B virus-related hepatocellular carcinoma with diverse differentiation grades","volume":"13","author":"Zhang","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbalip.2020.158658_bb0790","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.bbcan.2017.06.002","article-title":"Implications of the lysophosphatidic acid signaling axis in liver cancer","volume":"1868","author":"Lopane","year":"2017","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.bbalip.2020.158658_bb0795","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/onc.2010.517","article-title":"Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression","volume":"30","author":"Park","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.bbalip.2020.158658_bb0800","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/hep.24485","article-title":"Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts","volume":"54","author":"Mazzocca","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.bbalip.2020.158658_bb0805","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ccell.2016.11.004","article-title":"Molecular liver cancer prevention in cirrhosis by organ transcriptome analysis and lysophosphatidic acid pathway inhibition","volume":"30","author":"Nakagawa","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbalip.2020.158658_bb0810","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1158\/0008-5472.CAN-14-1607","article-title":"Lysophosphatidic acid receptor LPAR6 supports the tumorigenicity of hepatocellular carcinoma","volume":"75","author":"Mazzocca","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbalip.2020.158658_bb0815","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/01.mcg.0000225642.90898.0e","article-title":"Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C","volume":"41","author":"Watanabe","year":"2007","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.bbalip.2020.158658_bb0820","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103532","article-title":"Serum autotaxin is a parameter for the severity of liver cirrhosis and overall survival in patients with liver cirrhosis\u2014a prospective cohort study","volume":"9","author":"Pleli","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2020.158658_bb0825","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/hep.28973","article-title":"Hepatocyte autotaxin expression promotes liver fibrosis and cancer","volume":"65","author":"Kaffe","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.bbalip.2020.158658_bb0830","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.cca.2014.03.006","article-title":"Increased serum autotaxin levels in hepatocellular carcinoma patients were caused by background liver fibrosis but not by carcinoma","volume":"433","author":"Kondo","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbalip.2020.158658_bb0835","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jss.2012.10.037","article-title":"Lysophospholipid variants in hepatocellular carcinoma","volume":"182","author":"Skill","year":"2013","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.bbalip.2020.158658_bb0840","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19051366","article-title":"Emerging roles of G protein-coupled receptors in hepatocellular carcinoma","volume":"19","author":"Peng","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbalip.2020.158658_bb0845","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jss.2009.09.005","article-title":"Hepatocellular carcinoma associated lipid metabolism reprogramming","volume":"169","author":"Skill","year":"2011","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.bbalip.2020.158658_bb0850","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.bbalip.2011.09.009","article-title":"Phosphatidylcholine biosynthesis and lipoprotein metabolism","volume":"1821","author":"Cole","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2020.158658_bb0855","doi-asserted-by":"crossref","DOI":"10.1515\/hsz-2018-0441","article-title":"ABCB4\/MDR3 in health and disease - at the crossroads of biochemistry and medicine","author":"Prescher","year":"2019","journal-title":"Biol. Chem."},{"key":"10.1016\/j.bbalip.2020.158658_bb0860","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/carcin\/bgv156","article-title":"Deficiency of multidrug resistance 2 contributes to cell transformation through oxidative stress","volume":"37","author":"Tebbi","year":"2016","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbalip.2020.158658_bb0865","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1478-3231.2005.01033.x","article-title":"Hepatobiliary transporter expression in human hepatocellular carcinoma","volume":"25","author":"Zollner","year":"2005","journal-title":"Liver Int."},{"key":"10.1016\/j.bbalip.2020.158658_bb0870","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0940-2993(00)80071-8","article-title":"Enhancement of hepatocarcinogenesis initiated with diethylnitrosamine or N-nitrosobis(2-hydroxypropyl)amine by a choline-deficient, L-amino acid-defined diet administered prior to the carcinogen exposure in rats","volume":"52","author":"Kishida","year":"2000","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.bbalip.2020.158658_bb0875","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-1-4899-0949-7_6","article-title":"Choline and hepatocarcinogenesis in the rat","volume":"375","author":"Zeisel","year":"1995","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbalip.2020.158658_bb0880","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jhep.2007.01.030","article-title":"Prevention of hepatocarcinogenesis with phosphatidylcholine and menaquinone-4: in vitro and in vivo experiments","volume":"47","author":"Sakakima","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbalip.2020.158658_bb0885","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0009-8981(75)90086-8","article-title":"Plasma and red blood cell phospholipids in chronic liver diseases","volume":"60","author":"Cantoni","year":"1975","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbalip.2020.158658_bb0890","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130346","article-title":"Circulating lipids are associated with alcoholic liver cirrhosis and represent potential biomarkers for risk assessment","volume":"10","author":"Meikle","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2020.158658_bb0895","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.jhep.2016.01.003","article-title":"Multivariate metabotyping of plasma predicts survival in patients with decompensated cirrhosis","volume":"64","author":"McPhail","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbalip.2020.158658_bb0900","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41598-017-18610-5","article-title":"Functional isolation of tumor-initiating cells using microfluidic-based migration identifies phosphatidylserine decarboxylase as a key regulator","volume":"8","author":"Chen","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbalip.2020.158658_bb0905","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000072341","article-title":"Expression of phosphatidylethanolamine N-methyltransferase in human hepatocellular carcinomas","volume":"65","author":"Tessitore","year":"2003","journal-title":"Oncology"},{"key":"10.1016\/j.bbalip.2020.158658_bb0910","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/(SICI)1097-0215(20000501)86:3<362::AID-IJC10>3.0.CO;2-A","article-title":"Inactivation of phosphatidylethanolamine N-methyltransferase-2 in aflatoxin-induced liver cancer and partial reversion of the neoplastic phenotype by PEMT transfection of hepatoma cells","volume":"86","author":"Tessitore","year":"2000","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbalip.2020.158658_bb0915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0005-2760(97)00011-8","article-title":"Induction of hepatocyte proliferation after partial hepatectomy is accompanied by a markedly reduced expression of phosphatidylethanolamine N-methyltransferase-2","volume":"1346","author":"Houweling","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2020.158658_bb0920","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.bbalip.2012.08.016","article-title":"Formation and function of phosphatidylserine and phosphatidylethanolamine in mammalian cells","volume":"1831","author":"Vance","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2020.158658_bb0925","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/cdd.2016.11","article-title":"Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer","volume":"23","author":"Birge","year":"2016","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbalip.2020.158658_bb0930","doi-asserted-by":"crossref","DOI":"10.1007\/s11523-019-00663-3","article-title":"Efficacy and safety of bavituximab in combination with sorafenib in advanced hepatocellular carcinoma: a single-arm, open-label, phase II clinical trial","author":"Mokdad","year":"2019","journal-title":"Target. Oncol."},{"key":"10.1016\/j.bbalip.2020.158658_bb0935","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0009-8981(70)90395-5","article-title":"Plasma phospholipids in cirrhosis of liver and fatty liver","volume":"27","author":"Kunz","year":"1970","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbalip.2020.158658_bb0940","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0092-8674(00)80696-0","article-title":"PIP2 and PIP3: complex roles at the cell surface","volume":"100","author":"Czech","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.bbalip.2020.158658_bb0945","article-title":"Hepatocellular carcinoma: molecular mechanisms and targeted therapies","volume":"55","author":"Alqahtani","year":"2019","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.bbalip.2020.158658_bb0950","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.celrep.2014.12.010","article-title":"p53 mutations change phosphatidylinositol acyl chain composition","volume":"10","author":"Naguib","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbalip.2020.158658_bb0955","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1053\/j.gastro.2016.01.032","article-title":"The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent","volume":"150","author":"Mancina","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbalip.2020.158658_bb0960","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1038\/s41598-017-04991-0","article-title":"MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals","volume":"7","author":"Donati","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbalip.2020.158658_bb0965","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12944-018-0685-9","article-title":"Plasmalogen lipids: functional mechanism and their involvement in gastrointestinal cancer","volume":"17","author":"Messias","year":"2018","journal-title":"Lipids Health Dis."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198120300500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198120300500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T10:05:25Z","timestamp":1761386725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388198120300500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":193,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S1388198120300500"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2020.158658","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of lipids in pathophysiology, diagnosis and therapy of hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbalip.2020.158658","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"158658"}}